On January 20, 2025, the National Medical Products Administration approvedSynaptic Medical Technology (Beijing) Co., Ltd.'s "Cryotherapy Ablation System"Innovative Product Registration Application, Registration Certificate No.: GuoXieZhuZhun 20253010184.

This product consists of a main unit, a coaxial fluid connector tube, and connecting cables. It is used in conjunction with the balloon-type cryoablation catheter produced by the same company. Utilizing dual pressure and flow control technology, it achieves stable balloon pressure during inflation and ablation processes by real-time monitoring and control of refrigerant flow and balloon pressure.This technology can effectively reduce the risk of balloon bounce displacement caused by pressure fluctuations during pulmonary vein occlusion and ablation, used for treating adult patients with drug-refractory, recurrent, symptomatic paroxysmal atrial fibrillation.